Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/3/2026NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
  • 4/3/2026Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...
  • 4/3/2026Recent Executive Moves
  • 4/3/2026Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
  • 4/3/2026XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
  • 4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
  • 4/3/2026BDGene Secures Strategic Financing, Relocates Headquarters to Hangzhou...
  • 4/3/2026Earendil Advances AI-Designed TL1A Antibody Into Mid-Stage UC Trial
  • 4/3/2026Abbisko Advances ABSK061 Into US Clinical Development for Achondroplas...
  • 4/3/2026CDE Revises Drug R&D and Technical Review Communication Management Mea...
  • 4/2/2026NMPA Releases Implementation Opinions on "AI + Drug Regulation"
  • 4/2/2026NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
  • 4/1/2026Salubris Unveils Long-Acting Blood Pressure siRNA Data at ACC 2026
  • 4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...
  • 4/1/2026Bayer Secures Nearly Five-Year China Patent Extension for Kerendia
  • 4/1/2026China CDE Opens Public Consultation on 105th Batch of Chemical Generic...
  • 4/1/2026China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...
  • 4/1/2026Fosun Pharma Wins China Trial Nod for Teva-Partnered FXB0871
  • 4/1/2026Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
  • 4/1/2026Erasca Secures Worldwide Rights to Joyo's Pan-RAS Molecular Glue with ...
  • 4/1/2026Abbisko Wins EMA Orphan Drug Designation for Irpagratinib in Liver Can...
  • 3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
  • 3/31/2026Syneron Bio Closes Major Series B to Advance AI-Driven Macrocyclic Pep...
  • 3/31/2026Biocytogen Licenses RenNano® Antibody Discovery Platform to Taisho Ph...
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework
  • 3/31/2026CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...
  • 3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
  • 3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
  • 3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
  • Page:1/62 Total number of articles:1832: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group